Trials / Unknown
UnknownNCT05725759
Rehabilitation in SOD1 ALS Treated With Tofersen
The Effects of Rehabilitation on Functional Outcomes in Patients With SOD1 ALS Treated With Tofersen
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (estimated)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to document and describe the effects of a personalized rehabilitation program for patients with SOD1 ALS participating in the tofersen expanded access program. Participants currently receiving tofersen treatment will be referred to outpatient physical and/or occupational therapy. Participants will have an initial assessment performed and an individualized rehabilitation program will be prescribed. Each participant is encouraged to follow the prescribed recommendations that will include scheduled outpatient therapy sessions, functional assessments, and/or a home-based rehabilitation program. Functional assessments will be done at a minimum of every three months.
Conditions
- Amyotrophic Lateral Sclerosis
- Lou Gehrig Disease
- Familial Amyotrophic Lateral Sclerosis
- Motor Neuron Disease
- Motor Neuron Disease, Familial
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Rehabilitation | Particapants currently receiving tofersen treatment will be referred to outpatient physical and/or occupational therapy. |
Timeline
- Start date
- 2022-11-08
- Primary completion
- 2024-12-01
- Completion
- 2024-12-01
- First posted
- 2023-02-13
- Last updated
- 2024-01-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05725759. Inclusion in this directory is not an endorsement.